Sweden
· Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 18.74 billion. The enterprise value is 18.19 billion.
| Market Cap | 18.74B |
| Enterprise Value | 18.19B |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.37 million shares outstanding. The number of shares has decreased by -0.68% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 88.37M |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 33.93% |
| Owned by Institutions (%) | 49.21% |
| Float | 52.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 174.49 |
| PS Ratio | 112.00 |
| PB Ratio | 20.39 |
| P/TBV Ratio | 20.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -78.10 |
| EV / Sales | 108.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -106.62 |
Financial Position
The company has a current ratio of 8.35, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.35 |
| Quick Ratio | 5.10 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.75% and return on invested capital (ROIC) is -15.18%.
| Return on Equity (ROE) | -22.75% |
| Return on Assets (ROA) | -13.70% |
| Return on Capital (ROIC) | -15.18% |
| Revenue Per Employee | 1.61M |
| Profits Per Employee | -2.24M |
| Employee Count | 88 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.95% in the last 52 weeks. The beta is -0.19, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -25.95% |
| 50-Day Moving Average | 174.83 |
| 200-Day Moving Average | 190.24 |
| Relative Strength Index (RSI) | 63.40 |
| Average Volume (20 Days) | 298,202 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 167.14 million and -232.86 million in losses. Loss per share was -2.64.
| Revenue | 167.14M |
| Gross Profit | 76.64M |
| Operating Income | -255.91M |
| Pretax Income | -221.27M |
| Net Income | -232.86M |
| EBITDA | -237.25M |
| EBIT | -255.91M |
| Loss Per Share | -2.64 |
Balance Sheet
The company has 604.47 million in cash and 56.38 million in debt, giving a net cash position of 548.10 million or 6.20 per share.
| Cash & Cash Equivalents | 604.47M |
| Total Debt | 56.38M |
| Net Cash | 548.10M |
| Net Cash Per Share | 6.20 |
| Equity (Book Value) | 918.63M |
| Book Value Per Share | 10.39 |
| Working Capital | 871.21M |
Cash Flow
In the last 12 months, operating cash flow was -163.14 million and capital expenditures -7.44 million, giving a free cash flow of -170.59 million.
| Operating Cash Flow | -163.14M |
| Capital Expenditures | -7.44M |
| Free Cash Flow | -170.59M |
| FCF Per Share | -1.93 |
Margins
Gross margin is 45.85%, with operating and profit margins of -153.11% and -139.32%.
| Gross Margin | 45.85% |
| Operating Margin | -153.11% |
| Pretax Margin | -132.38% |
| Profit Margin | -139.32% |
| EBITDA Margin | -141.95% |
| EBIT Margin | -153.11% |
| FCF Margin | n/a |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 0.68% |
| Earnings Yield | -1.24% |
| FCF Yield | -0.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |